Fig. 1.
Fig. 1. Correlation between prothrombin fragment F1+2 and urinary excretion of Isoprostane-F2-III in cirrhotic patients (A) and correlation between monocyte tissue factor antigen (○) and activity (•) and urinary excretion of Isoprostane-F2-III in cirrhotic patients (B).

Correlation between prothrombin fragment F1+2 and urinary excretion of Isoprostane-F2-III in cirrhotic patients (A) and correlation between monocyte tissue factor antigen (○) and activity (•) and urinary excretion of Isoprostane-F2-III in cirrhotic patients (B).

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal